Partnerships + Collaborations
Your Partner in Bringing
Cell Therapies to Life
At CTMC, we believe that successful partnerships are as unique as the therapies they support. Each program is customized to align perfectly with your specific modality, product, and patient journey.
Whether you’re developing TILs, CAR-T, or a novel vector, we offer flexible infrastructure, scientific rigor, and extensive regulatory expertise to accelerate your development, minimize risk, and use capital efficiently.
We work hand-in-hand with early-stage biotechs, academic innovators, and clinicians, sharing insights, tools, and responsibilities across development, quality, and manufacturing. By strategically collaborating with technology providers and material suppliers, we continuously enhance our ecosystem to foster smarter, faster progress.
Together, we partner with purpose, because every day is critical for patients.
Biotech Partnerships
CTMC partners with early-stage biotech companies and researchers to bring next-generation cell therapies forward. Through a collaborative, risk-sharing model and integrated technical, regulatory, and manufacturing expertise, we enable innovators to progress rapidly from preclinical proof-of-concept to clinical readiness.
Academic Collaborations
CTMC supports primary investigators, academic clinicians, and scientists to advance promising cell therapies from discovery to clinic. Through deep translational expertise and fully integrated development and manufacturing support, we collaborate to transform innovative research into impactful treatments for patients.
Rodabe Amaria, MD
Associate Professor, Department of Melanoma Medical Oncology
Cara Haymaker, PhD
Associate Professor, Department of Translational Molecular Pathology
Pavlos Msaouel, MD, PhD
Associate Professor, Department of Genitourinary Medical Oncology
Aung Naing, MD
Professor, Department of Investigational Cancer Therapeutics
Sattva Neelapu, MD
Professor, Department of Lymphoma – Myeloma
Luisa M. Solis Soto, MD
Associate Professor, Department of Translational Molecular Pathology
Samer A. Srour, MB ChB, MS
Associate Professor, Department of Stem Cell Transplantation and Cellular Therapy
+
Collaborations
Through collaborations with industry leaders in equipment and materials, we provide an integrated, best-in-class environment that streamlines development, enhances quality, and reduces risk.